We look beyond our domestic boundariesto seek unrealized value in life science
NS Investment (NSI) is an affiliated firm of Dong-A ST, a leading pharmaceutical company in the Republic of Korea. NSI was established in 2015 to independently manage venture capital funds and serve institutional investors in Korea. NSI is focused on meeting the financial objective of its fund investors. NSI seeks to link Korean investor capital with innovative companies beyond its domestic boarders and ultimately link entrepreneurs and science across continents. Together with KDB Capital and Paratus Investment, NSI is co-managing its first venture capital fund GBG-1. NSI has partnered with Meritz and launched its second fund "Meritz NS Global Bio Fund". Both funds will support life science companies in Korea, North America, and Europe.